Engineering
Chemicals
Biotechnology
Amyris
$3.939876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.19 (-4.51%) Today
-$0.09 (-2.24%) After Hours
Why Robinhood?
You can buy or sell Amyris and other stocks, options, ETFs, and crypto commission-free!
About
Amyris, Inc. Common Stock, also called Amyris, is an industrial biotechnology company, which engages in the provision of bioscience solutions. Read More It focuses on the research, development, manufacture, and sale of fuels and farnesene-derived products. Its products include cosmetics, flavors and fragrances, performance materials, diesel, jet fuel, and lubricants. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.
CEO
Employees
â
Headquarters
Emeryville, California
Founded
2003
Market Cap
257.64M
Price-Earnings Ratio
â
Dividend Yield
0.00
Average Volume
1.91M
High Today
$4.27
Low Today
$3.98
Open Price
$4.22
Volume
593.56K
52 Week High
$9.29
52 Week Low
$1.87
Collections
Engineering
Chemicals
Biotechnology
Cosmetics
Materials
Health
Retail
US
News
Yahoo FinanceMay 22
Zhang Investor Law Reminds Investors of June 3 Deadline in Securities Class Action Lawsuit Against Amyris, Inc. - AMRS
NEW YORK, NY / ACCESSWIRE / May 22, 2019 / Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Amyris, Inc.
Yahoo FinanceMay 21
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Amyris, Inc. Investors
RADNOR, Pa., May 21, 2019 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Amyris, Inc. (Nasdaq: AMRS) (âAmyrisâ) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against Amyris on behalf of those who purchased or otherwise acquired Amyris securities between March 15, 2018 and March 19, 2019, inclusive (the âClass Periodâ). Important Deadline Reminder: Investors who purchased Amy...
Seeking AlphaMay 21
Amyris BioDisrupt 2019 - The Good, The Bad, And The Noise
Last week, I attended the annual investment day, BioDisrupt, at the Amyris (AMRS) headquarters in Emeryville. Unless otherwise cited, all of the numbers below are taken from the talks at the event, which can be viewed here. There were some good news, some bad news, and some inconsequential news, which still are likely to become talking points for investors. I attempt to sort the news into the "Good", "Bad", and "Noise" buckets below. The Good Production. Amyris signed a deal with RaĂzen to build two new p...
Price Paid on Robinhood
26% Lower
Right Now
52 Week Low
$1.87
Average Price Paid
$5.29
52 Week High
$9.29
Earnings
-$0.81
-$0.34
$0.14
$0.61
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.42 per share
Actual
Expected May 31